2024
- The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development published in the Annals of Oncology
- ESMO Recommendations on clinical reporting of genomics test results for solid cancers published in the Annals of Oncology
- Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group published in the Annals of Oncology
- Additional webinar recordings in series on Precision Oncology: Genomics Guides Care – How to Prepare and Read Genomics Reports for Clinical Practice?; Molecular Tumour Board in Clinical Practice 2024; Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024
2023
- Webinar series on Precision Oncology: Genomics Guides Care - Update of the Recommendations for the Use of Next-Generation Sequencing (NGS) for Patients with Metastatic Cancer
2022
- Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations published in the Annals of Oncology
- ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group published in the Annals of Oncology
- Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification published in the Annals of Oncology
- ESCAT scores provided for genomic alterations with actionable drug matches in several ESMO Clinical Practice Guidelines
2021
- Programme development for a series of liquid biopsy webinars focusing on applications of liquid biopsy in breast, colorectal, prostate and lung cancers
- Programme development for a webinar on the role of HRD testing in cancer
- New Biomarker Factsheets release
- ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research published in the Annals of Oncology
2020
- ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer published in the Annals of Oncology
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group published in the Annals of Oncology
- Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group published in the Annals of Oncology
2019
- ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research published in the Annals of Oncology
- ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach published in the Annals of Oncology
- Germline-Focused Analysis of Tumour-Only Sequencing: Recommendations from the ESMO Precision Medicine Working Group published in the Annals of Oncology
- Several new Biomarker Factsheets
2018
- ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) published in the Annals of Oncology
- V-Learning module: BRCA Across Tumour Types
- V-Learning module: BRAF Mutations Across Cancers
2017
- Partner in the 7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer; support for the meeting bursary awards
- Fifth ESMO Symposium on Signalling Pathways in partnership with EACR on DNA damage response: from cancer biology to oncology practice
- Precision Medicine Glossary published in the Annals of Oncology
- V-Learning module: Mechanisms of TKI Resistance
- E-Learning module on New developments in epigenetics and potential clinical applications
2016
- Several new Biomarker Factsheets
- Two new V-Learning modules on Molecular Pathways in cancer
- Fourth ESMO Signalling Pathways Symposium on HER/EGFR family signalling
2015
- Factsheets in Biomarkers
- Update of Translational Research Handbook
- Update of ESMO Glossary in Molecular Biology with a new section on Molecular Techniques
- V-Learning module on Inhibition of MEK to Treat Cancer, Focusing on Melanoma
- Third ESMO Signalling Pathways Symposium on targeting the MAPK pathway: From RAS to MEK
- E-Learning module on Next-Generation Histopathological Diagnosis for Precision Medicine in Solid Cancers
2014
- Delivering precision medicine in oncology today and in future–the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO) published in the Annals of Oncology
- Second V-Learning module on Molecular Pathways in Cancer
- ESMO/BIG Curriculum in Translational Research in Breast Cancer
- The ESMO Translational Research and Personalised Medicine Working Group endorses Curriculum’s applicability for translational research training in any other tumour types
- Second ESMO Signalling Pathways Symposium on targeting the PI3K/AKT/mTOR pathway in cancer
ESMO Translational Research Working Group: Major Achievements
2013
- First V-Learning module on Molecular Pathways in Cancer
- E-Learning module on Circulating Tumour Cells
2011/2012
- Review of ESMO Glossary in Molecular Biology
- E-Learning module on mTOR Inhibition/Targeting in Solid Tumours
2010
- Organisation of meeting with European Thoracic Oncology Platform on translational research in lung cancer
2009
- Collaboration with E-learning Working Group on production of modules with translational research oriented topics
2007
- Collaboration with Publishing Working Group on content development for ESMO Handbook of Principles of Translational Research
2005
- Translational Research Working Group established
ESMO Personalised Medicine Task Force: Major achievements
2013
- First ESMO Signalling Pathways Symposium on targeting HER/EGFR family in cancer
- ESMO Guide for Patients in Personalised Medicine
- Webinar on personalised cancer treatment and patient stratification using NGS and other OMICs data
2012
- Personalised medicine focused video series
- Collaboration with ESMO Guidelines Working Group on development of personalised medicine section in guidelines on all tumour types where appropriate
- Personalised medicine section in OncologyPro-based Tumour Knowledge Portal
- Personalised Medicine Task Force established
Last update: May 2024